Lupus

Top Story

FDA approves self-injectable formulation of Benlysta for lupus

July 21, 2017

The FDA has approved a self-injectable formulation of Benlysta for patients with systemic lupus erythematosus, according to a company press release.

“We are delighted with today’s decision,” Vlad Hogenhuis, senior vice president and head of specialty care at GlaxoSmithKline, said in the release. “Lupus can impact the lives of patients in many different ways with varied and often unpredictable symptoms.

In the Journals

Researchers identify new genetic markers in patients with lupus

July 21, 2017
Among patients with lupus, researchers have identified new genetic markers that predispose patients to the disease, according to a recently published study. “This…
In the Journals

European researchers publish recommendations for child-onset lupus

July 20, 2017
European researchers recently published recommendations for child-onset lupus, as well as neuropsychiatric child-onset lupus. “It must be noted that good quality…
In the Journals

Cumulative hydroxychloroquine and aspirin may prevent cardiovascular events in patients with SLE

July 14, 2017
In patients with lupus, ongoing use of hydroxychloroquine plus low-dose aspirin may be associated with increased effectiveness in the primary prevention of…
CME

Psoriatic Arthritis

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with psoriatic arthritis.
More »
Video
Meeting News Coverage

VIDEO: Rigby discusses the role of complement in inflammation

March 15, 2016
More »
Resource Centers
Biosimilars in the US

Biosimilars in the US

Advertisement
Advertisement